Remove Financial Market Remove Pharmaceutical Remove Planning
article thumbnail

Fundamental Analysis Of Tata Chemicals – Financials, Future Plans & More

Trade Brains

After this, we’ll quickly move through the financials of the stock. A highlight of the future plans of the company and a summary conclude the article at the end. Additionally, it also develops prebiotics and formulations among other products for the pharmaceutical industry. Financial Year Debt / Equity Interest Coverage 2023 0.32

article thumbnail

Deepak Nitrite Vs Deepak Fertilisers – Financials, Future Plans & More

Trade Brains

Next, we’ll go through their financials. Lastly, a highlight of their future plans and a summary conclude the article. FY 2022-23 Annual Report Its chemicals find their end applications in a multitude of industries including petrochemicals, rubber, agrochemicals, paper, pharmaceuticals, detergents, and more.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fundamental Analysis of Laxmi Organic Industries – Future Plans & More

Trade Brains

Next, we’ll look at the market size and opportunities. After this, we’ll race through the financials of the stock. A highlight of the future plans and a summary conclude the article at the end. Furthermore, it also has domestic leadership in Diketene derivatives with a 55% market share.

Planning 105
article thumbnail

Fundamental Analysis Of Divis Laboratories – Profitability & More

Trade Brains

Some notable pharmaceutical companies have made their way to the Nifty Index and we’re going to perform a fundamental analysis of Divis Laboratories. Overview: Indian Pharmaceutical Industry When you consume medicine for certain ailments and diseases, you’re recommended by your doctor to consume it for its curing effect.

article thumbnail

Fundamental Analysis Of Aarti Industries – Financials & Growth Potential

Trade Brains

Fundamental Analysis Of Aarti Industries : Specialty chemicals have become essential in various industries ranging from pharmaceuticals, electronics, agriculture, and automotive. Following that, we’ll go into the stock’s financials. The article concludes with a highlight of future plans and a summary.

article thumbnail

Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More

Trade Brains

It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. According to the Economic Survey 2023, India’s domestic pharmaceutical market was estimated at $41 billion. The roots of India’s pharmaceutical capabilities lay deep within its rich history. Kallam Anji Reddy.

article thumbnail

Fundamental Analysis of Glenmark Life Sciences – Future Plans & More

Trade Brains

Fundamental Analysis of Glenmark Life Sciences: For some time now, Glenmark Life Sciences, a listed subsidiary of Glenmark Pharmaceuticals has been in the news. A highlight of the R&D spending, future plans and a summary conclude the article at the end. GPL) set up its active pharmaceutical ingredient (API) business.